MedPath

Physical Activity, Insulin Resistance and Function of Fat Tissue in the Offspring of Patients With Type 2 Diabetes

Not Applicable
Completed
Conditions
Type 2 Diabetes Mellitus
Cardiovascular Diseases
Registration Number
NCT00268541
Lead Sponsor
NHS Greater Glasgow and Clyde
Brief Summary

Offspring of patients with type 2 diabetes have increased risk of developing diabetes and are typically more insulin resistant than their peers with no diabetes family history. We have recently demonstrated that, in contrast to their sedentary counterparts, physically active offspring are not insulin resistant. In the proposed controlled clinical study, we will examine the effects of a moderate exercise programme on insulin resistance, and other metabolic risk factors, in sedentary offspring and matched control subjects. We hypothesise that offspring will exhibit an augmented response to exercise, thereby normalising their predisposition to an adverse metabolic profile. We will also investigate expression of adipokines and other genes in adipose tissue to determine whether these contribute to the increased insulin resistance observed in offspring and whether they are influenced by exercise. The results will help to determine the efficacy of exercise in normalising metabolism in offspring and will help elucidate the mechanisms involved.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • 2 subject groups - 'control' and 'offspring'
  • Offspring - at least 1 parent diagnosed with type 2 diabetes before age 65
  • Controls - no history of type 2 diabetes in 1st or 2nd degree relatives
  • In generally good health
  • Non-smoker
  • Fasting glucose < 7 mmol/l
  • Blood pressure <160/90 mm Hg
  • No established CHD (e.g. MI, stroke, CABG, PCTA)
Exclusion Criteria
  • Established CHD (e.g. MI, stroke, CABG, PCTA)
  • diabetes
  • smoking
  • hypertension (BP > 160/90 mmHg)
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Insulin resistance at 8 weeks
Risk markers for cardiovascular disease/diabetes at 8 weeks
Adipose tissue gene expression at 8 weeks
Secondary Outcome Measures
NameTimeMethod
Fitness at 8 weeks
Body composition/adiposity at 8 weeks

Trial Locations

Locations (1)

University of Glasgow

🇬🇧

Glasgow, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath